These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 317109)

  • 1. N-Alkylated 2-aminotetralins: central dopamine-receptor stimulating activity.
    Hacksell U; Svensson U; Nilsson JL; Hjorth S; Carlsson A; Wikström H; Lindenberg P; Sanchez D
    J Med Chem; 1979 Dec; 22(12):1469-75. PubMed ID: 317109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resolved cis- and trans-2-amino-5-methoxy-1-methyltetralins: central dopamine receptor agonists and antagonists.
    Johansson AM; Arvidsson LE; Hacksell U; Nilsson JL; Svensson K; Carlsson A
    J Med Chem; 1987 Apr; 30(4):602-11. PubMed ID: 3560156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C1-Methylated 5-hydroxy-2-(dipropylamino)tetralins: central dopamine-receptor stimulating activity.
    Hacksell U; Johansson AM; Arvidsson L; Nilsson JL; Hjorth S; Carlsson A; Wikström H; Sanchez D; Lindberg P
    J Med Chem; 1984 Aug; 27(8):1003-7. PubMed ID: 6431102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 8-Hydroxy-2-(alkylamino)tetralins and related compounds as central 5-hydroxytryptamine receptor agonists.
    Arvidsson LE; Hacksell U; Johansson AM; Nilsson JL; Lindberg P; Sanchez D; Wikström H; Svensson K; Hjorth S; Carlsson A
    J Med Chem; 1984 Jan; 27(1):45-51. PubMed ID: 6418888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resolved N,N-dialkylated 2-amino-8-hydroxytetralins: stereoselective interactions with 5-HT1A receptors in the brain.
    Björk L; Höök BB; Nelson DL; Andén NE; Hacksell U
    J Med Chem; 1989 Apr; 32(4):779-83. PubMed ID: 2522991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C3-methylated 5-hydroxy-2-(dipropylamino)tetralins: conformational and steric parameters of importance for central dopamine receptor activation.
    Johansson AM; Nilsson JL; Karlén A; Hacksell U; Svensson K; Carlsson A; Kenne L; Sundell S
    J Med Chem; 1987 Jul; 30(7):1135-44. PubMed ID: 3599021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-methyl,N-propargyl-2-aminotetralins:novel dopamine agonists with monoamine oxidase inhibiting properties.
    Hazelhoff B; De Vries JB; Dijkstra D; Mulder TB; Horn AS
    Eur J Pharmacol; 1985 Feb; 109(2):229-40. PubMed ID: 3922776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and dopaminergic activity of some halogenated mono- and dihydroxylated 2-aminotetralins.
    Weinstock J; Gaitanopoulos DE; Oh HJ; Pfeiffer FR; Karash CB; Venslavsky JW; Sarau HM; Flaim KE; Hieble JP; Kaiser C
    J Med Chem; 1986 Sep; 29(9):1615-27. PubMed ID: 2875183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel dopamine receptor agonists and antagonists with preferential action on autoreceptors.
    Johansson AM; Arvidsson LE; Hacksell U; Nilsson JL; Svensson K; Hjorth S; Clark D; Carlsson A; Sanchez D; Andersson B
    J Med Chem; 1985 Aug; 28(8):1049-53. PubMed ID: 3927002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo dopamine autoreceptor selectivity appears to be critically dependent upon the aromatic hydroxyl position in a series of N,N-disubstituted 2-aminotetralins.
    Van Oene JC; De Vries JB; Dijkstra D; Renkema RJ; Tepper PG; Horn AS
    Eur J Pharmacol; 1984 Jun; 102(1):101-15. PubMed ID: 6434327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QSAR of N-alkylated 2-aminotetralins as central dopamine receptor stimulating agents.
    Lien EJ; Nilsson JL
    Acta Pharm Suec; 1983; 20(4):271-6. PubMed ID: 6637518
    [No Abstract]   [Full Text] [Related]  

  • 12. 6,7-Dihydroxy-3-chromanamine: synthesis and pharmacological activity of an oxygen isostere of the dopamine agonist 6,7-dihydroxy-2-aminotetralin.
    Horn AS; Kaptein B; Mulder TB; de Vries JB; Wynberg H
    J Med Chem; 1984 Oct; 27(10):1340-3. PubMed ID: 6090664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resolved monophenolic 2-aminotetralins and 1,2,3,4,4a,5,6,10b-octahydrobenzo[f]quinolines: structural and stereochemical considerations for centrally acting pre- and postsynaptic dopamine-receptor agonists.
    Wikström H; Andersson B; Sanchez D; Lindberg P; Arvidsson LE; Johansson AM; Nilsson JL; Svensson K; Hjorth S; Carlsson A
    J Med Chem; 1985 Feb; 28(2):215-25. PubMed ID: 3968686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (+)-cis-8-Hydroxy-1-methyl-2-(di-n-propylamino)tetralin: a potent and highly stereoselective 5-hydroxytryptamine receptor agonist.
    Arvidsson LE; Johansson AM; Hacksell U; Nilsson JL; Svensson K; Hjorth S; Magnusson T; Carlsson A; Andersson B; Wikström H
    J Med Chem; 1987 Nov; 30(11):2105-9. PubMed ID: 2959776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A homologous series of N-alkylated cis-(+)-(1 S, 2 R)-5-methoxy-1-methyl-2-aminotetralins: central dopamine receptor antagonists showing profiles ranging from classical antagonism to selectivity for autoreceptors.
    Svensson K; Carlsson A; Johansson AM; Arvidsson LE; Nilsson JL
    J Neural Transm; 1986; 65(1):29-38. PubMed ID: 3958706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further characterization of structural requirements for agonists at the striatal dopamine D2 receptor and a comparison with those at the striatal dopamine D1 receptor. Studies with a series of monohydroxyaminotetralins on acetylcholine release from rat striatum.
    Seiler MP; Markstein R
    Mol Pharmacol; 1984 Nov; 26(3):452-7. PubMed ID: 6238231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationships of dopaminergic 5-hydroxy-2-aminotetralin derivatives with functionalized N-alkyl substituents.
    Seiler MP; Stoll AP; Closse A; Frick W; Jaton A; Vigouret JM
    J Med Chem; 1986 Jun; 29(6):912-7. PubMed ID: 3712381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monophenolic octahydrobenzo[f]quinolines: central dopamine- and serotonin-receptor stimulating activity.
    Wikström H; Sanchez D; Lindberg P; Arvidsson LE; Hacksell U; Johansson A; Nilsson JL; Hjorth S; Carlsson A
    J Med Chem; 1982 Aug; 25(8):925-31. PubMed ID: 6811743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure--activity relationships of n-substituted dopamine and 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene analogues: behavioral effects in lesioned and reserpinized mice.
    Ginos JZ; Stevens JM; Nichols DE
    J Med Chem; 1979 Nov; 22(11):1323-9. PubMed ID: 574901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-substituted 1,2,3,4,4a,5,6,10b-octahydrobenzo[f]quinolines and 3-phenylpiperidines: effects on central dopamine and sigma receptors.
    Wikström H; Andersson B; Elebring T; Svensson K; Carlsson A; Largent B
    J Med Chem; 1987 Dec; 30(12):2169-74. PubMed ID: 2824773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.